1. Home
  2. ALTI vs ZVRA Comparison

ALTI vs ZVRA Comparison

Compare ALTI & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AlTi Global Inc.

ALTI

AlTi Global Inc.

N/A

Current Price

$3.16

Market Cap

492.8M

Sector

Finance

ML Signal

N/A

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

N/A

Current Price

$11.72

Market Cap

562.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ALTI
ZVRA
Founded
2020
2006
Country
United States
United States
Employees
490
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
492.8M
562.2M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
ALTI
ZVRA
Price
$3.16
$11.72
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$23.00
AVG Volume (30 Days)
155.0K
791.7K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
41.11
159.21
EPS
N/A
0.74
Revenue
$254,956,000.00
$106,470,000.00
Revenue This Year
$18.06
$37.27
Revenue Next Year
$10.71
$53.42
P/E Ratio
N/A
$15.74
Revenue Growth
23.21
350.91
52 Week Low
$2.75
$7.16
52 Week High
$5.45
$15.04

Technical Indicators

Market Signals
Indicator
ALTI
ZVRA
Relative Strength Index (RSI) 36.49 46.03
Support Level $2.87 $11.39
Resistance Level $3.97 $12.19
Average True Range (ATR) 0.21 0.44
MACD -0.08 -0.03
Stochastic Oscillator 21.07 17.22

Price Performance

Historical Comparison
ALTI
ZVRA

About ALTI AlTi Global Inc.

AlTi Global Inc is a wealth and investment partner to families, foundations, and institutions, helping clients activate capital, bring structure to complexity, and plan across borders and generations. The company combines the breadth of an international firm with the service offering of a family office to deliver solutions for wealth and capital. It provides services including discretionary and non-discretionary investment advisory, estate and wealth planning, trust and fiduciary, governance, philanthropy, and family office services, along with access to alternative investment opportunities. The company generates revenue from management, advisory, trustee, or administration fees, performance or incentive fees, distributions from investments, and other income or fees.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: